Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Common neural signatures of psychedelics: Frequency-specific energy changes and repertoire expansion revealed using connectome-harmonic decomposition.

Atasoy S, Vohryzek J, Deco G, Carhart-Harris RL, Kringelbach ML.

Prog Brain Res. 2018;242:97-120. doi: 10.1016/bs.pbr.2018.08.009. Epub 2018 Oct 25.

PMID:
30471684
2.

Predicting Responses to Psychedelics: A Prospective Study.

Haijen ECHM, Kaelen M, Roseman L, Timmermann C, Kettner H, Russ S, Nutt D, Daws RE, Hampshire ADG, Lorenz R, Carhart-Harris RL.

Front Pharmacol. 2018 Nov 2;9:897. doi: 10.3389/fphar.2018.00897. eCollection 2018.

3.

How do psychedelics work?

Carhart-Harris RL.

Curr Opin Psychiatry. 2019 Jan;32(1):16-21. doi: 10.1097/YCO.0000000000000467.

PMID:
30394903
4.

More Realistic Forecasting of Future Life Events After Psilocybin for Treatment-Resistant Depression.

Lyons T, Carhart-Harris RL.

Front Psychol. 2018 Oct 12;9:1721. doi: 10.3389/fpsyg.2018.01721. eCollection 2018.

5.

Whole-Brain Multimodal Neuroimaging Model Using Serotonin Receptor Maps Explains Non-linear Functional Effects of LSD.

Deco G, Cruzat J, Cabral J, Knudsen GM, Carhart-Harris RL, Whybrow PC, Logothetis NK, Kringelbach ML.

Curr Biol. 2018 Oct 8;28(19):3065-3074.e6. doi: 10.1016/j.cub.2018.07.083. Epub 2018 Sep 27.

PMID:
30270185
6.

Psychedelics, Meditation, and Self-Consciousness.

Millière R, Carhart-Harris RL, Roseman L, Trautwein FM, Berkovich-Ohana A.

Front Psychol. 2018 Sep 4;9:1475. doi: 10.3389/fpsyg.2018.01475. eCollection 2018.

7.

Serotonin, psychedelics and psychiatry.

Carhart-Harris RL.

World Psychiatry. 2018 Oct;17(3):358-359. doi: 10.1002/wps.20555. No abstract available.

8.

DMT Models the Near-Death Experience.

Timmermann C, Roseman L, Williams L, Erritzoe D, Martial C, Cassol H, Laureys S, Nutt D, Carhart-Harris R.

Front Psychol. 2018 Aug 15;9:1424. doi: 10.3389/fpsyg.2018.01424. eCollection 2018.

9.

Effects of psilocybin therapy on personality structure.

Erritzoe D, Roseman L, Nour MM, MacLean K, Kaelen M, Nutt DJ, Carhart-Harris RL.

Acta Psychiatr Scand. 2018 Nov;138(5):368-378. doi: 10.1111/acps.12904. Epub 2018 Jun 19.

10.

Psilocybin and MDMA reduce costly punishment in the Ultimatum Game.

Gabay AS, Carhart-Harris RL, Mazibuko N, Kempton MJ, Morrison PD, Nutt DJ, Mehta MA.

Sci Rep. 2018 May 29;8(1):8236. doi: 10.1038/s41598-018-26656-2.

11.

Correction to: The hidden therapist: evidence for a central role of music in psychedelic therapy.

Kaelen M, Giribaldi B, Raine J, Evans L, Timmermann C, Rodriguez N, Roseman L, Feilding A, Nutt D, Carhart-Harris R.

Psychopharmacology (Berl). 2018 May;235(5):1623. doi: 10.1007/s00213-018-4886-8.

12.

The entropic brain - revisited.

Carhart-Harris RL.

Neuropharmacology. 2018 Nov;142:167-178. doi: 10.1016/j.neuropharm.2018.03.010. Epub 2018 Mar 14. Review.

PMID:
29548884
13.

Psychedelics and the essential importance of context.

Carhart-Harris RL, Roseman L, Haijen E, Erritzoe D, Watts R, Branchi I, Kaelen M.

J Psychopharmacol. 2018 Jul;32(7):725-731. doi: 10.1177/0269881118754710. Epub 2018 Feb 15.

PMID:
29446697
14.

Natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depression.

Carrillo F, Sigman M, Fernández Slezak D, Ashton P, Fitzgerald L, Stroud J, Nutt DJ, Carhart-Harris RL.

J Affect Disord. 2018 Apr 1;230:84-86. doi: 10.1016/j.jad.2018.01.006.

PMID:
29407543
15.

The hidden therapist: evidence for a central role of music in psychedelic therapy.

Kaelen M, Giribaldi B, Raine J, Evans L, Timmerman C, Rodriguez N, Roseman L, Feilding A, Nutt D, Carhart-Harris R.

Psychopharmacology (Berl). 2018 Feb;235(2):505-519. doi: 10.1007/s00213-017-4820-5. Epub 2018 Feb 2. Erratum in: Psychopharmacology (Berl). 2018 Mar 26;:.

16.

Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression.

Roseman L, Nutt DJ, Carhart-Harris RL.

Front Pharmacol. 2018 Jan 17;8:974. doi: 10.3389/fphar.2017.00974. eCollection 2017.

17.

Increased nature relatedness and decreased authoritarian political views after psilocybin for treatment-resistant depression.

Lyons T, Carhart-Harris RL.

J Psychopharmacol. 2018 Jul;32(7):811-819. doi: 10.1177/0269881117748902. Epub 2018 Jan 17.

18.

Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression.

Roseman L, Demetriou L, Wall MB, Nutt DJ, Carhart-Harris RL.

Neuropharmacology. 2018 Nov;142:263-269. doi: 10.1016/j.neuropharm.2017.12.041. Epub 2017 Dec 27.

19.

Connectome-harmonic decomposition of human brain activity reveals dynamical repertoire re-organization under LSD.

Atasoy S, Roseman L, Kaelen M, Kringelbach ML, Deco G, Carhart-Harris RL.

Sci Rep. 2017 Dec 15;7(1):17661. doi: 10.1038/s41598-017-17546-0.

20.

Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.

Carhart-Harris RL, Bolstridge M, Day CMJ, Rucker J, Watts R, Erritzoe DE, Kaelen M, Giribaldi B, Bloomfield M, Pilling S, Rickard JA, Forbes B, Feilding A, Taylor D, Curran HV, Nutt DJ.

Psychopharmacology (Berl). 2018 Feb;235(2):399-408. doi: 10.1007/s00213-017-4771-x. Epub 2017 Nov 8.

21.

LSD modulates effective connectivity and neural adaptation mechanisms in an auditory oddball paradigm.

Timmermann C, Spriggs MJ, Kaelen M, Leech R, Nutt DJ, Moran RJ, Carhart-Harris RL, Muthukumaraswamy SD.

Neuropharmacology. 2018 Nov;142:251-262. doi: 10.1016/j.neuropharm.2017.10.039. Epub 2017 Nov 20.

PMID:
29101022
22.

Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression.

Stroud JB, Freeman TP, Leech R, Hindocha C, Lawn W, Nutt DJ, Curran HV, Carhart-Harris RL.

Psychopharmacology (Berl). 2018 Feb;235(2):459-466. doi: 10.1007/s00213-017-4754-y. Epub 2017 Oct 30.

23.

Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms.

Carhart-Harris RL, Roseman L, Bolstridge M, Demetriou L, Pannekoek JN, Wall MB, Tanner M, Kaelen M, McGonigle J, Murphy K, Leech R, Curran HV, Nutt DJ.

Sci Rep. 2017 Oct 13;7(1):13187. doi: 10.1038/s41598-017-13282-7.

24.

Serotonin and brain function: a tale of two receptors.

Carhart-Harris RL, Nutt DJ.

J Psychopharmacol. 2017 Sep;31(9):1091-1120. doi: 10.1177/0269881117725915. Epub 2017 Aug 31. Review.

25.

Psychedelics and connectedness.

Carhart-Harris RL, Erritzoe D, Haijen E, Kaelen M, Watts R.

Psychopharmacology (Berl). 2018 Feb;235(2):547-550. doi: 10.1007/s00213-017-4701-y. Epub 2017 Aug 10.

PMID:
28795211
26.

Psychedelics, Personality and Political Perspectives.

Nour MM, Evans L, Carhart-Harris RL.

J Psychoactive Drugs. 2017 Jul-Aug;49(3):182-191. doi: 10.1080/02791072.2017.1312643. Epub 2017 Apr 26.

PMID:
28443703
27.

The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future.

Carhart-Harris RL, Goodwin GM.

Neuropsychopharmacology. 2017 Oct;42(11):2105-2113. doi: 10.1038/npp.2017.84. Epub 2017 Apr 26. Review.

28.

Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin.

Schartner MM, Carhart-Harris RL, Barrett AB, Seth AK, Muthukumaraswamy SD.

Sci Rep. 2017 Apr 19;7:46421. doi: 10.1038/srep46421.

29.

Psychedelics and the science of self-experience.

Nour MM, Carhart-Harris RL.

Br J Psychiatry. 2017 Mar;210(3):177-179. doi: 10.1192/bjp.bp.116.194738.

PMID:
28249943
30.

Concerns regarding conclusions made about LSD-treatments (received 25 October 2016).

Erritzoe D, Nutt DJ, Carhart-Harris R.

Hist Psychiatry. 2017 Jun;28(2):257-260. doi: 10.1177/0957154X17692197. Epub 2017 Feb 15. No abstract available.

PMID:
28198192
31.

Altered Insula Connectivity under MDMA.

Walpola IC, Nest T, Roseman L, Erritzoe D, Feilding A, Nutt DJ, Carhart-Harris RL.

Neuropsychopharmacology. 2017 Oct;42(11):2152-2162. doi: 10.1038/npp.2017.35. Epub 2017 Feb 14.

32.

Question-based Drug Development for psilocybin - Authors' reply.

Carhart-Harris RL, Nutt DJ.

Lancet Psychiatry. 2016 Sep;3(9):807. doi: 10.1016/S2215-0366(16)30217-6. No abstract available.

PMID:
27568266
33.

Ego-Dissolution and Psychedelics: Validation of the Ego-Dissolution Inventory (EDI).

Nour MM, Evans L, Nutt D, Carhart-Harris RL.

Front Hum Neurosci. 2016 Jun 14;10:269. doi: 10.3389/fnhum.2016.00269. eCollection 2016.

34.

Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study.

Carhart-Harris RL, Bolstridge M, Rucker J, Day CM, Erritzoe D, Kaelen M, Bloomfield M, Rickard JA, Forbes B, Feilding A, Taylor D, Pilling S, Curran VH, Nutt DJ.

Lancet Psychiatry. 2016 Jul;3(7):619-27. doi: 10.1016/S2215-0366(16)30065-7. Epub 2016 May 17.

35.

LSD-induced entropic brain activity predicts subsequent personality change.

Lebedev AV, Kaelen M, Lövdén M, Nilsson J, Feilding A, Nutt DJ, Carhart-Harris RL.

Hum Brain Mapp. 2016 Sep;37(9):3203-13. doi: 10.1002/hbm.23234. Epub 2016 May 6.

36.

LSD alters eyes-closed functional connectivity within the early visual cortex in a retinotopic fashion.

Roseman L, Sereno MI, Leech R, Kaelen M, Orban C, McGonigle J, Feilding A, Nutt DJ, Carhart-Harris RL.

Hum Brain Mapp. 2016 Aug;37(8):3031-40. doi: 10.1002/hbm.23224. Epub 2016 Apr 29.

37.

Increased Global Functional Connectivity Correlates with LSD-Induced Ego Dissolution.

Tagliazucchi E, Roseman L, Kaelen M, Orban C, Muthukumaraswamy SD, Murphy K, Laufs H, Leech R, McGonigle J, Crossley N, Bullmore E, Williams T, Bolstridge M, Feilding A, Nutt DJ, Carhart-Harris R.

Curr Biol. 2016 Apr 25;26(8):1043-50. doi: 10.1016/j.cub.2016.02.010. Epub 2016 Apr 13.

38.

LSD modulates music-induced imagery via changes in parahippocampal connectivity.

Kaelen M, Roseman L, Kahan J, Santos-Ribeiro A, Orban C, Lorenz R, Barrett FS, Bolstridge M, Williams T, Williams L, Wall MB, Feilding A, Muthukumaraswamy S, Nutt DJ, Carhart-Harris R.

Eur Neuropsychopharmacol. 2016 Jul;26(7):1099-109. doi: 10.1016/j.euroneuro.2016.03.018. Epub 2016 Apr 12.

PMID:
27084302
39.

Neural correlates of the LSD experience revealed by multimodal neuroimaging.

Carhart-Harris RL, Muthukumaraswamy S, Roseman L, Kaelen M, Droog W, Murphy K, Tagliazucchi E, Schenberg EE, Nest T, Orban C, Leech R, Williams LT, Williams TM, Bolstridge M, Sessa B, McGonigle J, Sereno MI, Nichols D, Hellyer PJ, Hobden P, Evans J, Singh KD, Wise RG, Curran HV, Feilding A, Nutt DJ.

Proc Natl Acad Sci U S A. 2016 Apr 26;113(17):4853-8. doi: 10.1073/pnas.1518377113. Epub 2016 Apr 11.

40.

A placebo-controlled investigation of synaesthesia-like experiences under LSD.

Terhune DB, Luke DP, Kaelen M, Bolstridge M, Feilding A, Nutt D, Carhart-Harris R, Ward J.

Neuropsychologia. 2016 Jul 29;88:28-34. doi: 10.1016/j.neuropsychologia.2016.04.005. Epub 2016 Apr 5.

41.

Decreased mental time travel to the past correlates with default-mode network disintegration under lysergic acid diethylamide.

Speth J, Speth C, Kaelen M, Schloerscheidt AM, Feilding A, Nutt DJ, Carhart-Harris RL.

J Psychopharmacol. 2016 Apr;30(4):344-53. doi: 10.1177/0269881116628430.

42.

The paradoxical psychological effects of lysergic acid diethylamide (LSD).

Carhart-Harris RL, Kaelen M, Bolstridge M, Williams TM, Williams LT, Underwood R, Feilding A, Nutt DJ.

Psychol Med. 2016 May;46(7):1379-90. doi: 10.1017/S0033291715002901. Epub 2016 Feb 5.

43.

LSD enhances the emotional response to music.

Kaelen M, Barrett FS, Roseman L, Lorenz R, Family N, Bolstridge M, Curran HV, Feilding A, Nutt DJ, Carhart-Harris RL.

Psychopharmacology (Berl). 2015 Oct;232(19):3607-14. doi: 10.1007/s00213-015-4014-y. Epub 2015 Aug 11.

44.

Finding the self by losing the self: Neural correlates of ego-dissolution under psilocybin.

Lebedev AV, Lövdén M, Rosenthal G, Feilding A, Nutt DJ, Carhart-Harris RL.

Hum Brain Mapp. 2015 Aug;36(8):3137-53. doi: 10.1002/hbm.22833. Epub 2015 May 22.

PMID:
26010878
45.

Drug models of schizophrenia.

Steeds H, Carhart-Harris RL, Stone JM.

Ther Adv Psychopharmacol. 2015 Feb;5(1):43-58. doi: 10.1177/2045125314557797. Review.

46.
47.

Homological scaffolds of brain functional networks.

Petri G, Expert P, Turkheimer F, Carhart-Harris R, Nutt D, Hellyer PJ, Vaccarino F.

J R Soc Interface. 2014 Dec 6;11(101):20140873.

48.

LSD enhances suggestibility in healthy volunteers.

Carhart-Harris RL, Kaelen M, Whalley MG, Bolstridge M, Feilding A, Nutt DJ.

Psychopharmacology (Berl). 2015 Feb;232(4):785-94. doi: 10.1007/s00213-014-3714-z. Epub 2014 Sep 23.

PMID:
25242255
49.

Enhanced repertoire of brain dynamical states during the psychedelic experience.

Tagliazucchi E, Carhart-Harris R, Leech R, Nutt D, Chialvo DR.

Hum Brain Mapp. 2014 Nov;35(11):5442-56. doi: 10.1002/hbm.22562. Epub 2014 Jul 3.

PMID:
24989126
50.

The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers.

Roseman L, Leech R, Feilding A, Nutt DJ, Carhart-Harris RL.

Front Hum Neurosci. 2014 May 27;8:204. doi: 10.3389/fnhum.2014.00204. eCollection 2014.

Supplemental Content

Loading ...
Support Center